Leukoreduction filtration of blood with sickle cell trait

Transfusion Medicine Reviews

Volumn 18, Issue 3, 2004, Pages 168-176

  Schuetz, Audrey N ^a   Hillyer, Krista L ^a   Roback, John D ^a,b   Hillyer, Christopher D ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

ALLOIMMUNIZATION; BLOOD FILTRATION; BLOOD TRANSFUSION REACTION; ERYTHROCYTE TRANSFUSION; HLA SYSTEM; HUMAN; LEUKOCYTE; OSMOLARITY; OXYGEN SATURATION; PH; REDUCTION; REVIEW; SICKLE CELL; TEMPERATURE SENSITIVITY; VIRUS TRANSMISSION;

EID: 3242719691     PISSN: 08877963     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tmrv.2004.03.002     Document Type: Article

References (42)

1. Dzik W.H., Szczepiorkowski Z.M. Leukocyte reduced products. Hillyer C., Silberstein L.E., Ness P.M., et al. Blood Banking and Transfusion Medicine Basic Principles & Practice. 2003;219-240 Churchill Livingstone, Philadelphia, PA
2. Hoyer J.D., Hoffman D.R. The thalassemia and hemoglobinopathy syndromes. McClatchey K.D. Clinical Laboratory Medicine. ed 2 :2002;Lippincott Williams & Wilkins, Philadelphia, PA. 866-865
3. Krailadsiri P., Gilcher R., Seghatchian J. Leukoreduction of sickle cell trait blood An unresolved issue. Transfus Apheresis Sci. 24:2001;223-225
4. Ashley-Koch A., Yang Q., Olney R.S. Sickle hemoglobin (HbS) allele and sickle cell disease A HuGE review. Am J Epidemiol. 151:2000;839-845
5. Epstein J.S. The U.S. blood supply. Am Fam Physician. 61:2000;549-550
6. Hiruma H., Noguchi C.T., Uyesaka N., et al. Contributions of sickle hemoglobin polymer and sickle cell membranes to impaired filterability. Am J Physiol Heart Circ Physiol. 268:1995;H2003-H2008
7. Hasegawa S., Hiruma H., Uyesaka N., et al. Filterability of mixtures of sickle and normal erythrocytes. Am J Hematol. 50:1995;91-97
8. Hipp M.J., Scott R.B. Altered filterability of CPD-stored sickle trait donor blood. Transfusion. 14:1974;447-452
9. Singer K., Singer L. The gelling phenomenon of sickle cell hemoglobin Its biologic and diagnostic significance. Blood. 8:1953;1008-1023
10. Boral L.I., Weiss E.D., Henry J.B. Tranfusion medicine. Henry J.B. Clinical Diagnosis and Management by Laboratory Methods. ed 20 :2001;718-775 Saunders, Philadelphia, PA
11. Roush K.S. Febrile, allergic, and other noninfectious transfusion reactions. Hillyer C., Silberstein L.E., Ness P.M., et al. Blood Banking and Transfusion Medicine Basic Principles & Practice. 2003;401-411 Churchill Livingstone, Philadelphia, PA
12. Perrotta P.L., Snyder E.L. Non-infectious complications of transfusion therapy. Blood Rev. 15:2001;69-83
13. Kadar J.G. Leukocyte-reduced blood products. Transfus Med. 5:1998;381-385
14. Snyder E.L. Clinical use of white cell-poor blood components. Transfusion. 29:1989;568-571
15. Sirchia G., Parravicini A., Rebulla P., et al. Effectiveness of red blood cells filtered through cotton wool to prevent antileukocyte antibody production in multitransfused patients. Vox Sang. 42:1982;190-197
16. Al E.J.M, Visser S.C.E, Broersen S.M., et al. Reduction of HTLV-I-infected cells in blood by leukocyte filtration. Ann Hematol. 67:1993;295-300
17. Eisenfeld L., Silver H., McLaughlin J., et al. Prevention of transfusion-associated cytomegalovirus infection in neonatal patients by the removal of white cells from blood. Transfusion. 32:1992;205-209
18. The Trial to Reduce Alloimmunization to Platelets Study Group. Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions. Anonymous N Engl J Med. 337:1997;1861-1869
19. Oksanen K., Kekomäki R., Ruutu T., et al. Prevention of alloimmunization in patients with acute leukemia by the use of white cell reduced blood components - A randomized trial. Transfusion. 31:1991;588-594
20. Sniecinski I., O'Donnell M.R., Nowicki B., et al. Prevention of refractoriness and HLA-alloimmunization using filtered blood products. Blood. 71:1988;1402-1407
21. Reverberi R., Menini C. Clinical efficacy of five filters specific for leukocyte removal. Vox Sang. 58:1990;188-191
22. Bruil A., Beugeling T., Feijen J., et al. The mechanisms of leukocyte removal by filtration. Transfus Med Rev. 9:1995;145-166
23. Vengelen-Tyler V. American Association of Blood Banks Technical Manual. ed 14 :2002;American Association of Blood Banks, Bethesda, MD
24. Dzik S. Leukodepletion blood filters Filter design and mechanisms of leukocyte removal. Transfus Med Rev. 7:1993;65-77
25. Stroncek D.F., Rainer T., Sharon V., et al. Sickle Hb polymerization in RBC components from donors with sickle cell trait prevents effective WBC reduction by filtration. Transfusion. 42:2002;1466-1472
26. 2α. Prostaglandins. 13:1977;281-309
27. Beard M.J., Seghatchian J., Cardigan R., et al. Leucofiltration of sickle cell trait blood "the blocker" NBS London & S.E. experience. Transfus Sci. 22:2000;71-73
28. Gorlin J.B., Adams C.L., Stefan M.M., et al. Variable leukoreduction of units from donors with sickle cell trait A time-temperature, donor reproducibility study. Transfusion. 40:2000;55S. (abstr)
29. Tinmouth A.T., Naiman R., Garel C. Sickle cell trait associated with filter obstruction during pre-storage leukodepletion of red blood cell products. Transfusion. 40:2000;59S. (abstr)
30. Ould Amar A.K., Cesaire R., Kerob-Bauchet B., et al. Altered filterability of fresh sickle cell trait donor blood. Vox Sang. 73:1997;55-56. letter
31. Hillyer K.L., Rapaport H., Roback J.D., et al. Pre-filtration oxygenation abrogates the leukoreduction filtration lesion in hemoglobin AS whole blood units. Blood. 100:2002;287a. (abstr, suppl 11s)
32. Messer M.J., Harris J.W. Filtration characteristics of sickle cells Rates of alteration of filterability after deoxygenation and reoxygenation, and correlations with sickling and unsickling. J Lab Clin Med. 76:1970;537-547
33. Mijovic V., Kruse A. Filtration of blood from donors with HbAS An unexpected problem. Brozovic B. The Role of Leukocyte Depletion in Blood Transfusion Practice Proceedings of the International Workshop. 1989;48-50 Blackwell Scientific, Oxford
34. Bodensteiner D. White cell reduction in blood from donors with sickle cell trait. Transfusion. 34:1994;84. (letter)
35. Gorlin J.B., Gudino M.D. A sticky situation WBC reduction of RBCs from donors with sickle cell trait. Transfusion. 41:2001;1192
36. Leitman S.F., Sharon V., Noguchi C.T., et al. Collection of sickle cell trait red cells by apheresis allows leukocyte reduction by filtration. Blood. 98:2001;829a. (abstr, suppl 11)
37. Kline L., George G., Luban N.L.C, et al. Leukoreduction of red cells from donors with sickle cell trait (SCT). Transfusion. 41:2001;64S. (abstr)
38. Lankford K.V., Fields A.C., Langley P.C., et al. Ineffective prestorage leukoreduction (PSLR) of whole blood (WB) from African-American donors with sickle cell trait (HB AS) versus controls. Transfusion. 39:1999;108S. (abstr)
39. Williamson L.M., Beard M., Seghatchian J., et al. Leukocyte depletion of whole blood and red cells from donors with hemoglobin sickle trait. Transfusion. 39:1999;108S. (abstr)
40. Novak R.W., Brown R.E. Multiple renal and splenic infarctions in a neonate following transfusion with sickle trait blood. Clin Pediatr. 21:1982;239-241
41. Murphy R.J., Malhotra C., Sweet A.Y. Death following an exchange transfusion with hemoglobin SC blood. J Pediatr. 96:1980;110-112
42. Prihoda L., Harbin K., Thomas A. Leukocyte-reduction filter "failures" Is hemoglobin S the answer? Transfusion. 40:2000;55S. (abstr)